Literature DB >> 11423116

Genes modulated by histone acetylation as new effectors of butyrate activity.

F Della Ragione1, V Criniti, V Della Pietra, A Borriello, A Oliva, S Indaco, T Yamamoto, V Zappia.   

Abstract

A wealth of evidence correlates the chemopreventive activity of a fiber-rich diet with the production of butyrate. In order to identify the genes transcriptionally modulated by the molecule, we analyzed the expression profile of butyrate-treated colon cancer cells by means of cDNA expression arrays. Moreover, the effect of trichostatin A, a specific histone deacetylase inhibitor, was studied. A superimposable group of 23 genes out of 588 investigated is modulated by both butyrate and trichostatin A. Among them, a major target was tob-1, a gene involved in the control of cell cycle. tob-1 is also up-regulated by butyrate in a neuroblastoma-derived cell line, and its overexpression in the colon cells caused growth arrest. Our findings represent an extensive analysis of genes modulated by butyrate and identify completely new effectors of its biological activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423116     DOI: 10.1016/s0014-5793(01)02539-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

1.  P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.

Authors:  K Bajbouj; C Mawrin; R Hartig; J Schulze-Luehrmann; A Wilisch-Neumann; A Roessner; R Schneider-Stock
Journal:  J Neurooncol       Date:  2012-01-20       Impact factor: 4.130

2.  Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.

Authors:  Yehua Gan; Ying H Shen; Jian Wang; Xinwen Wang; Budi Utama; Jing Wang; Xing Li Wang
Journal:  J Biol Chem       Date:  2005-02-19       Impact factor: 5.157

3.  A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity.

Authors:  Yun Li; Gary D Kao; Benjamin A Garcia; Jeffrey Shabanowitz; Donald F Hunt; Jun Qin; Caroline Phelan; Mitchell A Lazar
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

4.  Novel therapies for peripheral T-cell lymphomas.

Authors:  Andrei Shustov
Journal:  Ther Adv Hematol       Date:  2013-06

Review 5.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

6.  Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages.

Authors:  Sara L Coleman; Young-Ki Park; Ji-Young Lee
Journal:  Eur J Nutr       Date:  2010-11-03       Impact factor: 5.614

7.  Chromogranin A transcription and gene expression in Folliculostellate (TtT/GF) cells inhibit cell growth.

Authors:  Gail A Stilling; Jill M Bayliss; Long Jin; Heyu Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 8.  Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.

Authors:  Sabnam Parbin; Swayamsiddha Kar; Arunima Shilpi; Dipta Sengupta; Moonmoon Deb; Sandip Kumar Rath; Samir Kumar Patra
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

9.  Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice.

Authors:  Anti Kalda; Lenne-Triin Heidmets; Hai-Ying Shen; Alexander Zharkovsky; Jiang-Fan Chen
Journal:  Behav Brain Res       Date:  2007-03-31       Impact factor: 3.332

10.  Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.

Authors:  Sai Murali Krishna Pulukuri; Bharathi Gorantla; Jasti S Rao
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.